A next generation of sclerostin inhibitor with bone anabolic potential and without increasing cardiovascular risk for osteogenesis imperfecta: How does sclerostin loop3-specific aptamer work?

Project Details

StatusNot started
Effective start/end date1/01/2230/06/24